Home - Products - Others - Other Targets - Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor

Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor

CAS No. 81483-91-2

Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor( ——— )

Catalog No. M42126 CAS No. 81483-91-2

Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor
  • Description
    Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    81483-91-2
  • Formula Weight
    516.6
  • Molecular Formula
    C22H40N6O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cobolimab

    Cobolimab (TSR-022) is a potent monoclonal antibody to TIM-3. Cobolimab induces internalization of TIM-3 with an IC50 value of 0.4464 nM.

  • Hexadimethrine bromi...

    Hexadimethrine bromide is a synthetic polymer which agglutinates red blood cells, and used as a heparin antagonist.Hexadimethrine bromide inhibits human mesenchymal stem cell proliferation during lentiviral transduction.

  • 8-Hydroxyguanosine

    8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.